Indications and uses
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
before using this product read the enclosed consumer information leaflet for complete directions and information adults and children 12 years of age and over: suppositories: insert 1 suppository into the vagina at bedtime for 3 nights in a row. Throw applicator away after use. external cream: Use cap to puncture seal. Squeeze a small amount of cream onto your fingertip. Gently apply the cream onto the itchy, irrit...
do not use if suppository wrapper is missing or damaged (each suppository is individually wrapped) do not use if seal over tube opening has been punctured or is not visible do not purchase if carton is open store at room temperature 15°-30°C (59°-86°F). Avoid heat (over 30°C - 86°F)
Miconazole nitrate, USP 200 mg (in each suppository)
Miconazole nitrate, USP 2% (external cream)
Vaginal antifungal
For vaginal use only
if you have never had a vaginal yeast infection diagnosed by a doctor
taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
Call toll free: 1-800-287-1915
equate™
Compare to
Monistat®3
Active
Ingredients*
3 Day Treatment
Miconazole
Combination Pack
Miconazole Nitrate Vaginal Suppositories, USP 200 mg
Miconazole Nitrate External Vulvar Cream, 2%
Vaginal Antifungal
3 MICONAZOLE NITRATE VAGINAL SUPPOSITORIES, USP 200 mg PLUS
1 TUBE OF MICONAZOLE NITRATE EXTERNAL VULVAR CREAM - NET WT 0.32 OZ (9 g)

| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MICONAZOLE NITRATE | ACTIVE INGREDIENT | VW4H1CYW1K | 1 | |
| MICONAZOLE | ACTIVE MOIETY | 7NNO0D7S5M | 1 | |
| BENZOIC ACID | INACTIVE INGREDIENT | 8SKN0B0MIM | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 1 | |
| HYDROGENATED PALM KERNEL OIL | INACTIVE INGREDIENT | FM8D1RE2VP | 1 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 1 | |
| PEG-5 OLEATE | INACTIVE INGREDIENT | 0240V77G50 | 1 | |
| PEGOXOL 7 STEARATE | INACTIVE INGREDIENT | 3EW5AXE5X5 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49035-731 | 49035-731-43 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MICONAZOLE NITRATE | VW4H1CYW1K | ACTIB |
| HYDROGENATED PALM KERNEL OIL | FM8D1RE2VP | IACT |
| MICONAZOLE NITRATE | VW4H1CYW1K | ACTIB |
| BENZOIC ACID | 8SKN0B0MIM | IACT |
| BUTYLATED HYDROXYANISOLE | REK4960K2U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| APRICOT KERNEL OIL PEG-6 ESTERS | DRG3KJZ1TJ | IACT |
| PEGOXOL 7 STEARATE | 3EW5AXE5X5 | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | LOTION / TOPICAL | 0.2 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | OINTMENT / VAGINAL | 0.02 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SOLUTION / ORAL | 100 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SOLUTION / IRRIGATION | 0.02 %w/v | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | CAPSULE / ORAL | 4 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CREAM / TOPICAL | 6 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | SUSPENSION / ORAL | 2.5 mg/5ml | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | GEL / TOPICAL | 7 mg | ||
| PEGOXOL 7 STEARATE | PEGOXOL 7 STEARATE | 3EW5AXE5X5 | CREAM / TOPICAL | 640 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | CREAM / VAGINAL | 0.03 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| PEG-5 OLEATE | PEG-5 OLEATE | 0240V77G50 | CREAM / VAGINAL | 3 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | SYRUP / ORAL | 1 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | OINTMENT / TOPICAL | 0.01 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| PEG-5 OLEATE | PEG-5 OLEATE | 0240V77G50 | CREAM / TOPICAL | 98 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SOLUTION / TOPICAL | 0.1 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| PEGOXOL 7 STEARATE | PEGOXOL 7 STEARATE | 3EW5AXE5X5 | SUPPOSITORY / VAGINAL | 200 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | SUPPOSITORY / VAGINAL | 1 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | TABLET / ORAL | 8 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | CAPSULE, LIQUID FILLED / ORAL | 4 mg | ||
| PEG-5 OLEATE | PEG-5 OLEATE | 0240V77G50 | SOLUTION / ORAL | 1600 mg | ||
| PEGOXOL 7 STEARATE | PEGOXOL 7 STEARATE | 3EW5AXE5X5 | CREAM / VAGINAL | 20 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUSPENSION / RECTAL | 0.1 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | GRANULE, FOR SUSPENSION / ORAL | NA | ||
| PEG-5 OLEATE | PEG-5 OLEATE | 0240V77G50 | SUPPOSITORY / VAGINAL | 30 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUSPENSION / ORAL | 15 mg | ||
| PEGOXOL 7 STEARATE | PEGOXOL 7 STEARATE | 3EW5AXE5X5 | LOTION / TOPICAL | NA | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUPPOSITORY / VAGINAL | 2 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | LOTION / TOPICAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | TABLET / SUBLINGUAL | 2 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | ELIXIR / ORAL | 90 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | GEL / TOPICAL | 0.1 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CREAM / VAGINAL | 10 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | TABLET, EXTENDED RELEASE / ORAL | 1 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | TABLET, FILM COATED / ORAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | INJECTION / INTRAMUSCULAR | 5 %w/v | ||
| PEG-5 OLEATE | PEG-5 OLEATE | 0240V77G50 | LOTION / TOPICAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | INJECTION, SOLUTION / INTRAMUSCULAR | 0.2 %w/v |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074926-001 | M-ZOLE 3 COMBINATION PACK | MICONAZOLE NITRATE | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cc4f0b8d-f084-473e-94ed-dd682d14b2f1 | bb542dd6-560a-4dd3-9974-69209c6d1cef | 2023-01-19 | Warnings | cc4f0b8d-f084-473e-94ed-dd682d14b2f1 bb542dd6-560a-4dd3-9974-69209c6d1cef |
Adverse event summaries are temporarily unavailable. Other product information remains available.